Acrylamide Functional Group Incorporation Improves Drug-like Properties: An Example with EGFR Inhibitors.


Journal

ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073

Informations de publication

Date de publication:
10 Jan 2019
Historique:
received: 15 06 2018
accepted: 06 12 2018
entrez: 19 1 2019
pubmed: 19 1 2019
medline: 19 1 2019
Statut: epublish

Résumé

We demonstrate that the acrylamide group can be used to improve the drug-like properties of potential drug candidates. In the EGFR inhibitor development, both the solubility and membrane permeability properties of compounds

Identifiants

pubmed: 30655941
doi: 10.1021/acsmedchemlett.8b00270
pmc: PMC6331160
doi:

Types de publication

Journal Article

Langues

eng

Pagination

22-26

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Mol Divers. 2002;5(4):199-208
pubmed: 12549672
J Clin Oncol. 2003 Jun 15;21(12):2237-46
pubmed: 12748244
J Comput Aided Mol Des. 2005 Jun;19(6):453-63
pubmed: 16231203
J Med Chem. 2006 May 18;49(10):2969-78
pubmed: 16686538
Cancer Biol Ther. 2008 Apr;7(4):557-68
pubmed: 18296914
J Med Chem. 2008 Mar 27;51(6):1740-6
pubmed: 18318465
Bioorg Med Chem Lett. 2008 Sep 1;18(17):4872-5
pubmed: 18691886
J Med Chem. 2009 Mar 12;52(5):1231-46
pubmed: 19203292
J Chem Inf Model. 2009 Feb;49(2):308-17
pubmed: 19434832
J Biomol Screen. 2011 Mar;16(3):348-55
pubmed: 21343602
Nat Rev Drug Discov. 2011 Apr;10(4):307-17
pubmed: 21455239
Curr Oncol Rep. 2012 Feb;14(1):48-54
pubmed: 22012633
J Phys Chem A. 2012 Apr 12;116(14):3753-64
pubmed: 22432471
J Med Chem. 2012 Jul 26;55(14):6243-62
pubmed: 22621397
J Med Chem. 2013 Mar 28;56(6):2690-4
pubmed: 23432334
J Med Chem. 2014 Dec 11;57(23):10072-9
pubmed: 25375838
J Med Chem. 2015 Jan 22;58(2):814-26
pubmed: 25494040
Drug Metab Dispos. 2015 Mar;43(3):375-84
pubmed: 25504185
J Med Chem. 2015 Nov 12;58(21):8315-59
pubmed: 26200936
J Med Chem. 2015 Oct 22;58(20):8200-15
pubmed: 26313252
Chem Rev. 2016 Feb 24;116(4):2478-601
pubmed: 26812185
Nature. 2016 May 25;534(7605):129-32
pubmed: 27251290

Auteurs

Kuen-Da Wu (KD)

School of Pharmacy and Center for Innovative Therapeutics Discovery, National Taiwan University, Taipei 10055, Taiwan.

Grace Shiahuy Chen (GS)

Department of Applied Chemistry, Providence University, Taichung 43301, Taiwan.

Jia-Rong Liu (JR)

School of Pharmacy and Center for Innovative Therapeutics Discovery, National Taiwan University, Taipei 10055, Taiwan.

Chen-En Hsieh (CE)

Department of Applied Chemistry, Providence University, Taichung 43301, Taiwan.

Ji-Wang Chern (JW)

School of Pharmacy and Center for Innovative Therapeutics Discovery, National Taiwan University, Taipei 10055, Taiwan.

Classifications MeSH